Cerivastatin, an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase, Inhibits Endothelial Cell Proliferation Induced by Angiogenic Factors In Vitro and Angiogenesis in In Vivo Models

A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding

1976 • 225,752 citations

Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma

1991 • 5,657 citations

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1992 • 4,631 citations

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.

2000 • 1,427 citations

A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor.

1992 • 807 citations

Statins do more than just lower cholesterol

1996 • 714 citations

Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family

2001 • 662 citations

Regulation of G1 cyclin-dependent kinases in the mammalian cell cycle

2000 • 588 citations

The Unstable Atheroma

1997 • 568 citations

Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects

1995 • 553 citations

Angiogenesis and the atherosclerotic carotid plaque: An association between symptomatology and plaque morphology

1999 • 354 citations

Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study

2001 • 311 citations

Integrin-mediated signalling: regulation by protein tyrosine kinases and small GTP-binding proteins

1996 • 305 citations

Angiogenesis in human coronary atherosclerotic plaques.

1994 • 273 citations

Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis

1998 • 266 citations

Akt Takes Center Stage in Angiogenesis Signaling

2000 • 264 citations

A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis

1990 • 251 citations

Apoptosis in interleukin-3-dependent haemopoietic cells

1992 • 207 citations

Inhibition of endothelial cell migration by cerivastatin, an HMG‐CoA reductase inhibitor: contribution to its anti‐angiogenic effect

2001 • 204 citations

Immunohistochemical study of intimal microvessels in coronary atherosclerosis.

1993 • 203 citations

Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules.

1997 • 197 citations

Local neovascularization and cellular composition within vulnerable regions of atherosclerotic plaques of human carotid arteries

1999 • 171 citations

Oncostatin M Induces Angiogenesis In Vitro and In Vivo

1999 • 130 citations

Isoprenoid‐Mediated Inhibition of Mevalonate Synthesis: Potential Application to Cancer

1999 • 116 citations

RhoA Prenylation Is Required for Promotion of Cell Growth and Transformation and Cytoskeleton Organization but Not for Induction of Serum Response Element Transcription

2000 • 105 citations

Pravastatin: An Antithrombotic Effect Independent of the Cholesterol-lowering Effect

2000 • 103 citations

A geranylgeranyltransferase for rhoA p21 distinct from the farnesyltransferase for ras p21A

1991 • 68 citations

Mechanisms modifying atherosclerotic disease — from lipids to vascular biology

1999 • 60 citations

Isoprenoid-Mediated Inhibition of Mevalonate Synthesis: Potential Application to Cancer

1999 • 60 citations

Expression of angiogenic factor thymidine phosphorylase and angiogenesis in human atherosclerosis

2000 • 51 citations

The possible role of the arterial microcirculation in the pathogenesis of atherosclerosis

1980 • 39 citations

Mechanisms of acute coronary syndromes and the potential role of statins

2001 • 22 citations

Proliferation of CECs requires dual signaling through both MAPK/ERK and PI 3-K/Akt pathways.

2001 • 18 citations